FORMULARY EVALUATION OF 3RD-GENERATION CEPHALOSPORINS USING DECISION-ANALYSIS

被引：18

作者：

CANO, SB ^{[1
]}

FUJITA, NK ^{[1
]}

机构：

[1] HUMANA HOSP MT VIEW,INFECT CONTROL COMM,THORNTON,CO

来源：

AMERICAN JOURNAL OF HOSPITAL PHARMACY | 1988年 / 45卷 / 03期

关键词：

D O I：

10.1093/ajhp/45.3.566

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：566 / 569

页数：4

共 13 条

[1] BARR JT, 1986, CLIN PHARMACY, V5, P239
[2] BARRIERE SL, 1984, CLIN PHARMACY, V3, P351
[3] CONTROLLING CEPHALOSPORIN AND AMINOGLYCOSIDE COSTS THROUGH PHARMACY AND THERAPEUTICS COMMITTEE RESTRICTIONS
HAYMAN, JN
SBRAVATI, EC
[J]. AMERICAN JOURNAL OF HOSPITAL PHARMACY, 1985, 42 (06): : 1343 - 1347
[4] KRESEL JJ, 1987, HOSP FORMUL, V22, P658
[5] EVALUATION OF PHARMACY AND THERAPEUTICS COMMITTEE DRUG-EVALUATION REPORTS
MAJERCIK, PL
MAY, JR
LONGE, RL
JOHNSON, MH
[J]. AMERICAN JOURNAL OF HOSPITAL PHARMACY, 1985, 42 (05): : 1073 - 1076
[6] SCHUMACHER GE, 1986, CLIN PHARMACY, V5, P325
[7] Weinstein MC, 1980, CLIN DECISION ANAL
[8] DECISION-ANALYSIS APPLIED TO THE PURCHASE OF FROZEN PREMIXED INTRAVENOUS ADMIXTURES
WITTE, KW
ECK, TA
VOGEL, DP
[J]. AMERICAN JOURNAL OF HOSPITAL PHARMACY, 1985, 42 (04): : 835 - 839
[9] 1983, AM J HOSP PHARM, V40, P1384
[10] 1985, AM DRUGGIST BLUE BOO